AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 80 filers reported holding AGILE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 54,400 | +248.7% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 15,600 | -17.0% | 0.00% | – |
| Q3 2021 | $1,000 | -83.3% | 18,800 | -78.2% | 0.00% | – |
| Q2 2021 | $6,000 | -68.4% | 86,100 | -14.2% | 0.00% | -100.0% |
| Q1 2021 | $19,000 | +35.7% | 100,300 | +69.4% | 0.00% | – |
| Q4 2020 | $14,000 | -48.1% | 59,200 | +10.2% | 0.00% | -100.0% |
| Q3 2020 | $27,000 | +237.5% | 53,700 | +225.5% | 0.00% | – |
| Q2 2020 | $8,000 | +166.7% | 16,500 | +8.6% | 0.00% | – |
| Q1 2020 | $3,000 | – | 15,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,123,567 | $12,104,000 | 41.30% |
| ProQuest Associates IV LLC | 5,062,363 | $28,856,000 | 8.17% |
| Vivo Capital, LLC | 1,513,975 | $8,630,000 | 2.84% |
| Aisling Capital LLC | 1,804,933 | $10,288,000 | 2.39% |
| INVESTOR AB | 3,510,189 | $20,008,000 | 1.46% |
| AlpInvest Partners B.V. | 27,693 | $158,000 | 0.56% |
| Cormorant Asset Management, LP | 563,880 | $3,214,000 | 0.43% |
| PURA VIDA INVESTMENTS, LLC | 164,501 | $938,000 | 0.34% |
| Perceptive Advisors | 661,446 | $3,770,000 | 0.27% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 140,000 | $799,000 | 0.20% |